Clinical Trial Update: In-Vivo Activated T-Cell Depletion to Prevent GVHD [NA]

View source ↗

Summary

Indiana University conducted a terminated clinical trial evaluating in-vivo activated T-cell depletion to prevent graft-versus-host disease in patients with acu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Snippet

Sponsor: Indiana University | Conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia | NA | Status: TERMINATED | Results posted: 2012-03-20